Australia has taken a significant step toward securing its vaccine sovereignty, with Health Minister Mark Butler opening CSL Seqirus’ new $1 billion, state-of-the-art cell-based influenza vaccine and antivenom manufacturing facility in Melbourne. …
Seqirus opens world-class cell-based vaccine and antivenom manufacturing facility
December 2, 2025 Latest NewsBioPharmaAustralian Biotech
Latest Video
New Stories
-
Cost of multiple sclerosis in Australia surges as prevalence accelerates
December 3, 2025 - - Latest News -
Australia can increase prices in response to pressure, as it did just 36 months ago for 950 medicines
December 2, 2025 - - Latest News -
Reforming Australia’s Opioid Dependence Treatment Program - From red tape to person-centred care
December 2, 2025 - - Latest News -
Novo Nordisk raises over $106,000 for Type 1 Diabetes research
December 2, 2025 - - Latest News -
Seqirus opens world-class cell-based vaccine and antivenom manufacturing facility
December 2, 2025 - - Latest News -
CLINUVEL advances second therapy toward market with planned 2026 European filing
December 2, 2025 - - Australian Biotech -
Burnt-Out Australians rush to health appointments as year-end pressure peaks
December 2, 2025 - - Other Health